ArticleAnnals of intensive care2026
Venous excess and lung ultrasound during continuous renal replacement therapy in critically ill patients (VExLUS-RRT): a prospective observational study.
Article in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: No gold standard currently exists to evaluate fluid status during continuous renal replacement therapy (CRRT). We aimed to describe systemic venous congestion by using venous excess ultrasound (VExUS) and pulmonary congestion by lung ultrasound (LUS) in critically ill patients with acute kidney injury (AKI) who received CRRT. Methods: This was a single-centre prospective cohort study. Adult patients with AKI undergoing CRRT underwent serial ultrasound assessments on Day 1 and 3 by two independent operators. VExUS score and its individual components, including an inferior vena cava (IVC) diameter (≥2 cm), hepatic vein, portal vein, as well as intrarenal vein Doppler flow patterns, and 6-zone lung ultrasound (LUS) scores (ranged from 0 to 20 points), were collected. An exploratory modified VExUS (mVExUS) grading was derived by incorporating an IVC distensibility index (<18%) or collapsibility index (<50%). Venous congestion was defined as VExUS or mVExUS Grade ≥2. The primary descriptive outcome was the prevalence of venous congestion and serial LUS score changes. The principal clinical endpoint was the association between ultrasound parameters and 90-day mortality Results: Among 100 enrolled patients (median age 66 years, male 58%), baseline venous congestion was documented in 20% by VExUS score and 35% by mVExUS scores. The median LUS score was 4 (interquartile range 1-9). Baseline VExUS Grade 2-3 (Log rank p = 0.049) and mVExUS Grade 2-3 (Log rank p = 0.01) were associated with lower 90-day survival. In time-updated Cox models after adjustment for baseline Sequential Organ Failure Assessment score, hepatic vein Doppler Grade 2-3 (adjusted hazard ratio (aHR) 1.78; 95% confidence interval (CI) 1.05-3.01, p = 0.01) and higher LUS scores (aHR 1.04; 95% CI 1.001-1.08, p = 0.04) were independently associated with 90-day mortality. Unchanged or worsening LUS scores between Day 1 and Day 3 were associated with a significantly higher cumulative fluid balance compared to improved scores (p = 0.01). Conclusion: Systemic and pulmonary congestion assessed by multiorgan point-of-care ultrasound was associated with increased 90-day mortality in AKI patients receiving CRRT. Future studies should explore the utility of these tools in guiding individualised fluid management during CRRT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.